Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03574441
Other study ID # 1048027
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 4, 2017
Est. completion date March 18, 2018

Study information

Verified date July 2019
Source Augusta University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Failure of labor epidural is a well-recognized situation in obstetric anesthesia practice. Incidence of epidural failure was shown to be 12% in a retrospective analysis of 19,259 deliveries. Epidural migration has been documented in both the obstetric and non-obstetric settings. It has been argued that prevention of epidural displacement is a potential remedy to at least part of the incomplete or failed epidurals in obstetrics.

Purpose: The investigators propose this study to prospectively evaluate the efficacy of the three types of epidural catheter dressings that are currently in use in clinical practice, in terms of catheter migration, taking into consideration the influence of body mass index on this variable.


Description:

Primary aim: The investigators will evaluate the efficacy of three different epidural catheter dressing systems in laboring patients.

Secondary aims: To compare the effect of different degrees of obesity measured by BMI, on epidural catheter migration and quality and failure of epidural labor analgesia. To evaluate the effect of time an indwelling catheter remains in place, level of insertion and patient's height on epidural catheter migration.

Hypothesis: The use of dressing with transparent TegadermTM plus catheter support pad dressing is superior to the dressing with TegadermTM plus Steri-StripTM bands, and to a dressing with TegadermTM only, for epidural catheter fixation in laboring obese and morbidly obese patients, in terms of catheter migration. epidural quality and failure and epidural catheter replacement in the labor analgesia setting.


Recruitment information / eligibility

Status Completed
Enrollment 91
Est. completion date March 18, 2018
Est. primary completion date March 11, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Patients admitted to the Labor and delivery Unit at Augusta University Medical Center who request epidural analgesia.

2. BMI >30 kg/m2.

3. Age older than 18 years old.

Exclusion Criteria:

1. Allergy to adhesive tape or to the components of the dressings used in the study.

2. Preexisting sensory neurologic deficits affecting lower extremities.

3. Patients taken to the operating room for cesarean section during the study period.

4. Chronic pain conditions.

5. Patients with intrathecal catheters.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Tegaderm dressing + catheter support pad
Tegaderm TM is a transparent tape. This intervention adds a support pad that comes in the epidural kit to help secure the catheter
Tegaderm dressing + Steri-strip dressing
Tegaderm TM is a transparent tape. This intervention adds Steri Strips TM of tape to help secure the catheter
Tegaderm dressing only
Tegaderm TM is a transparent tape. This intervention uses only Tegaderm to secure the catheter

Locations

Country Name City State
United States Augusta University Augusta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Augusta University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Epidural Catheter Migration Percentage of participants for whom catheter migration was observed 24 hours. The time from insertion to removal of catheter
Secondary Rate of Epidural Catheter Replacement Frequency of epidural catheter replacement due to analgesic failure among the catheters in each arm 24 hours. The time from insertion to removal of catheter due to failure
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02557087 - Hyoscine ButylBromide for Intrapartum Analgesia Phase 2
Not yet recruiting NCT02578251 - Paracetamol for Intrapartum Analgesia Phase 2
Recruiting NCT06236126 - SKIN WHEAL - Subcutaneous or Intradermal Lidocaine in Epidural for Laboring Pain. N/A
Completed NCT02509312 - Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery Phase 4
Completed NCT02789410 - Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery N/A
Completed NCT05099055 - Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study Phase 3
Active, not recruiting NCT03167905 - CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery) Phase 2/Phase 3
Completed NCT02009722 - Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose Phase 4
Active, not recruiting NCT03805607 - IV Ketorolac on Platelet Function Post-Cesarean Delivery Phase 4
Completed NCT02920489 - Individualized Timing of Analgesia and Effectiveness of Labor Analgesia N/A
Completed NCT02823418 - Neuraxial Labor Analgesia and the Incidence of Postpartum Depression
Not yet recruiting NCT05977361 - Intrathecal Catheter Placement Versus Resiting Epidural Catheter After Dural Puncture in Obstetric Patients N/A